USSTOCK.TODAY
Market Closed
Log in Sign up

Moderna shares surge over 14% as NIH plans to accelerate cancer research

Nasdaq +1 ·

MRNA Moderna Inc
$225.00 +14.21%
View chart & analysis →
MRK +2.26%
  1. 1Moderna shares surged more than 14% on Friday.
  2. 2The National Institutes of Health (NIH) plans to launch a campaign in December to fast-track cancer treatment research.
  3. 3Moderna and Merck announced results for Intismelan (an mRNA-based therapy) on August 19.

So what's the key point?

Moderna's stock price rose significantly by more than 14 percent. The National Institutes of Health plans to speed up cancer research, which is good news for the company.

Source Nasdaq +1 · View original ↗

Related 3-line summaries

Moderna shares surge over 560%, but Wall Street deems them overvalued The Motley Fool +1 · 1h agoModerna and Eli Lilly Shares Rise as Healthcare Sector Gains Investopedia +2 · yesterdayNovavax and Moderna shares fall on WHO's low plague risk warning Yahoo Finance +1 · 3d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news